Do analysts rate ZYXI or TMDIF?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zynex 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is ZYXI or TMDIF more profitable?

Titan Medical has a net margin of 0.00% compared to Zynex's net margin of -68.35%. Titan Medical's return on equity of -82.31% beat Zynex's return on equity. Company Net Margins Return on Equity Return on Assets Zynex -68.35% -804.30% -36.67% Titan Medical N/A -82.31% -51.47%

Do analysts recommend ADGM or ZYXI?

Adagio Medical currently has a consensus price target of $3.50, indicating a potential upside of 676.91%. Given Adagio Medical's stronger consensus rating and higher probable upside, analysts plainly believe Adagio Medical is more favorable than Zynex. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adagio Medical 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Zynex 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is ADGM or ZYXI more profitable?

Adagio Medical has a net margin of 0.00% compared to Zynex's net margin of -68.35%. Adagio Medical's return on equity of -661.85% beat Zynex's return on equity. Company Net Margins Return on Equity Return on Assets Adagio Medical N/A -661.85% -73.35% Zynex -68.35% -804.30% -36.67%

Do analysts recommend ZYXI or ICU?

SeaStar Medical has a consensus price target of $8.00, suggesting a potential upside of 160.59%. Given SeaStar Medical's stronger consensus rating and higher probable upside, analysts plainly believe SeaStar Medical is more favorable than Zynex. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zynex 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SeaStar Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher valuation & earnings, ZYXI or ICU?

Zynex has higher revenue and earnings than SeaStar Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zynex $108.20M 0.04 $2.99M -$2.43 N/A SeaStar Medical $1.23M 11.01 -$12.15M -$3.91 N/A

Is ZYXI or ICU more profitable?

Zynex has a net margin of -68.35% compared to SeaStar Medical's net margin of -795.51%. SeaStar Medical's return on equity of -162.75% beat Zynex's return on equity. Company Net Margins Return on Equity Return on Assets Zynex -68.35% -804.30% -36.67% SeaStar Medical -795.51% -162.75% -109.89%

Do analysts rate ZYXI or IRIX?

IRIDEX has a consensus price target of $3.00, indicating a potential upside of 368.75%. Given IRIDEX's stronger consensus rating and higher probable upside, analysts clearly believe IRIDEX is more favorable than Zynex. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zynex 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 IRIDEX 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable valuation and earnings, ZYXI or IRIX?

Zynex has higher revenue and earnings than IRIDEX. IRIDEX is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zynex $108.20M 0.04 $2.99M -$2.43 N/A IRIDEX $52.67M 0.21 -$4.44M -$0.20 N/A

Is ZYXI or IRIX more profitable?

IRIDEX has a net margin of -6.88% compared to Zynex's net margin of -68.35%. IRIDEX's return on equity of 0.00% beat Zynex's return on equity. Company Net Margins Return on Equity Return on Assets Zynex -68.35% -804.30% -36.67% IRIDEX -6.88% N/A -12.55%

Do analysts recommend ZYXI or MBAI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zynex 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Check-Cap 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is ZYXI or MBAI more profitable?

Check-Cap has a net margin of 0.00% compared to Zynex's net margin of -68.35%. Check-Cap's return on equity of 0.00% beat Zynex's return on equity. Company Net Margins Return on Equity Return on Assets Zynex -68.35% -804.30% -36.67% Check-Cap N/A N/A N/A

Zynex (ZYXI) Competitors

$0.12 0.00 (0.00%)

As of 09/11/2026

Compare

ZYXI vs. TMDIF, ADGM, ICU, IRIX, and MBAI

Should you buy Zynex stock or one of its competitors? Zynex's main competitors and comparable companies include Titan Medical (TMDIF), Adagio Medical (ADGM), SeaStar Medical (ICU), IRIDEX (IRIX), and Check-Cap (MBAI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Zynex compare to Titan Medical?

Zynex (NASDAQ:ZYXI) and Titan Medical (NASDAQ:TMDIF) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, risk, institutional ownership, analyst recommendations, earnings and dividends.

Titan Medical has a net margin of 0.00% compared to Zynex's net margin of -68.35%. Titan Medical's return on equity of -82.31% beat Zynex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zynex	-68.35%	-804.30%	-36.67%
Titan Medical	N/A	-82.31%	-51.47%

In the previous week, Zynex's average media sentiment score of 0.00 equaled Titan Medical'saverage media sentiment score.

Company	Overall Sentiment
Zynex	Neutral
Titan Medical	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zynex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

29.7% of Zynex shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 49.3% of Zynex shares are owned by insiders. Comparatively, 0.0% of Titan Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Titan Medical has lower revenue, but higher earnings than Zynex. Zynex is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zynex	$108.20M	0.04	$2.99M	-$2.43	N/A
Titan Medical	$17.63M	0.78	$6.95M	$0.05	2.41

Zynex has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market. Comparatively, Titan Medical has a beta of 1.26, indicating that its stock price is 26% more volatile than the broader market.

Summary

Zynex and Titan Medical tied by winning 6 of the 12 factors compared between the two stocks.

How does Zynex compare to Adagio Medical?

Adagio Medical (NASDAQ:ADGM) and Zynex (NASDAQ:ZYXI) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk, analyst recommendations and media sentiment.

Adagio Medical currently has a consensus price target of $3.50, indicating a potential upside of 676.91%. Given Adagio Medical's stronger consensus rating and higher probable upside, analysts plainly believe Adagio Medical is more favorable than Zynex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Zynex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Adagio Medical has a beta of -0.09, suggesting that its stock price is 109% less volatile than the broader market. Comparatively, Zynex has a beta of 0.99, suggesting that its stock price is 1% less volatile than the broader market.

Zynex has higher revenue and earnings than Adagio Medical. Adagio Medical is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adagio Medical	N/A	N/A	-$25.08M	-$1.48	N/A
Zynex	$108.20M	0.04	$2.99M	-$2.43	N/A

Adagio Medical has a net margin of 0.00% compared to Zynex's net margin of -68.35%. Adagio Medical's return on equity of -661.85% beat Zynex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Adagio Medical	N/A	-661.85%	-73.35%
Zynex	-68.35%	-804.30%	-36.67%

In the previous week, Adagio Medical had 1 more articles in the media than Zynex. MarketBeat recorded 1 mentions for Adagio Medical and 0 mentions for Zynex. Adagio Medical's average media sentiment score of 1.87 beat Zynex's score of 0.00 indicating that Adagio Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Adagio Medical	Very Positive
Zynex	Neutral

48.1% of Adagio Medical shares are held by institutional investors. Comparatively, 29.7% of Zynex shares are held by institutional investors. 7.8% of Adagio Medical shares are held by company insiders. Comparatively, 49.3% of Zynex shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Adagio Medical beats Zynex on 9 of the 15 factors compared between the two stocks.

How does Zynex compare to SeaStar Medical?

Zynex (NASDAQ:ZYXI) and SeaStar Medical (NASDAQ:ICU) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, analyst recommendations, dividends, valuation, risk, institutional ownership and earnings.

In the previous week, SeaStar Medical had 2 more articles in the media than Zynex. MarketBeat recorded 2 mentions for SeaStar Medical and 0 mentions for Zynex. SeaStar Medical's average media sentiment score of 0.93 beat Zynex's score of 0.00 indicating that SeaStar Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Zynex	Neutral
SeaStar Medical	Positive

Zynex has a net margin of -68.35% compared to SeaStar Medical's net margin of -795.51%. SeaStar Medical's return on equity of -162.75% beat Zynex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zynex	-68.35%	-804.30%	-36.67%
SeaStar Medical	-795.51%	-162.75%	-109.89%

SeaStar Medical has a consensus price target of $8.00, suggesting a potential upside of 160.59%. Given SeaStar Medical's stronger consensus rating and higher probable upside, analysts plainly believe SeaStar Medical is more favorable than Zynex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zynex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

29.7% of Zynex shares are held by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are held by institutional investors. 49.3% of Zynex shares are held by company insiders. Comparatively, 0.7% of SeaStar Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Zynex has a beta of 0.99, meaning that its share price is 1% less volatile than the broader market. Comparatively, SeaStar Medical has a beta of -1.05, meaning that its share price is 205% less volatile than the broader market.

Zynex has higher revenue and earnings than SeaStar Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zynex	$108.20M	0.04	$2.99M	-$2.43	N/A
SeaStar Medical	$1.23M	11.01	-$12.15M	-$3.91	N/A

Summary

Zynex beats SeaStar Medical on 9 of the 16 factors compared between the two stocks.

How does Zynex compare to IRIDEX?

Zynex (NASDAQ:ZYXI) and IRIDEX (NASDAQ:IRIX) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation and risk.

29.7% of Zynex shares are held by institutional investors. Comparatively, 20.1% of IRIDEX shares are held by institutional investors. 49.3% of Zynex shares are held by company insiders. Comparatively, 8.6% of IRIDEX shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Zynex has higher revenue and earnings than IRIDEX. IRIDEX is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zynex	$108.20M	0.04	$2.99M	-$2.43	N/A
IRIDEX	$52.67M	0.21	-$4.44M	-$0.20	N/A

In the previous week, IRIDEX had 2 more articles in the media than Zynex. MarketBeat recorded 2 mentions for IRIDEX and 0 mentions for Zynex. IRIDEX's average media sentiment score of 0.43 beat Zynex's score of 0.00 indicating that IRIDEX is being referred to more favorably in the news media.

Company	Overall Sentiment
Zynex	Neutral
IRIDEX	Neutral

IRIDEX has a net margin of -6.88% compared to Zynex's net margin of -68.35%. IRIDEX's return on equity of 0.00% beat Zynex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zynex	-68.35%	-804.30%	-36.67%
IRIDEX	-6.88%	N/A	-12.55%

IRIDEX has a consensus price target of $3.00, indicating a potential upside of 368.75%. Given IRIDEX's stronger consensus rating and higher probable upside, analysts clearly believe IRIDEX is more favorable than Zynex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zynex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Zynex has a beta of 0.99, indicating that its share price is 1% less volatile than the broader market. Comparatively, IRIDEX has a beta of 0.62, indicating that its share price is 38% less volatile than the broader market.

Summary

IRIDEX beats Zynex on 10 of the 16 factors compared between the two stocks.

How does Zynex compare to Check-Cap?

Zynex (NASDAQ:ZYXI) and Check-Cap (NASDAQ:MBAI) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, earnings, valuation, media sentiment, profitability, analyst recommendations and dividends.

29.7% of Zynex shares are held by institutional investors. Comparatively, 1.1% of Check-Cap shares are held by institutional investors. 49.3% of Zynex shares are held by insiders. Comparatively, 0.5% of Check-Cap shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Zynex has a beta of 0.99, meaning that its share price is 1% less volatile than the broader market. Comparatively, Check-Cap has a beta of 0.67, meaning that its share price is 33% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zynex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Check-Cap	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Check-Cap had 3 more articles in the media than Zynex. MarketBeat recorded 3 mentions for Check-Cap and 0 mentions for Zynex. Check-Cap's average media sentiment score of 0.62 beat Zynex's score of 0.00 indicating that Check-Cap is being referred to more favorably in the news media.

Company	Overall Sentiment
Zynex	Neutral
Check-Cap	Positive

Check-Cap has a net margin of 0.00% compared to Zynex's net margin of -68.35%. Check-Cap's return on equity of 0.00% beat Zynex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zynex	-68.35%	-804.30%	-36.67%
Check-Cap	N/A	N/A	N/A

Check-Cap has lower revenue, but higher earnings than Zynex. Check-Cap is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zynex	$108.20M	0.04	$2.99M	-$2.43	N/A
Check-Cap	N/A	N/A	$4.14M	-$14.07	N/A

Summary

Zynex and Check-Cap tied by winning 6 of the 12 factors compared between the two stocks.

Get Zynex News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZYXI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ZYXI vs. The Competition

Export

Metric	Zynex	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$3.80M	$5.42B	$7.16B	$14.29B
Dividend Yield	N/A	1.80%	2.57%	11.70%
P/E Ratio	-0.05	25.11	273.30	25.37
Price / Sales	0.04	72.41	666.61	88.28
Price / Cash	0.51	33.03	28.42	34.96
Price / Book	0.11	6.03	10.39	6.24
Net Income	$2.99M	$150.14M	$3.49B	$358.08M
7 Day Performance	N/A	-1.37%	-1.12%	-0.70%
1 Month Performance	N/A	-3.26%	0.59%	-2.76%
1 Year Performance	-91.55%	9.56%	20.20%	6.72%

Zynex Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ZYXI Zynex	N/A	$0.13 flat	N/A	N/A	$3.80M	$108.20M	N/A	770
TMDIF Titan Medical	N/A	$0.13 +10.9%	N/A	-66.8%	$14.68M	$17.63M	N/A	50	Gap Down
ADGM Adagio Medical	3.1893 of 5 stars	$0.61 +7.7%	$3.50 +476.1%	-73.8%	$13.49M	$600K	N/A	87	Positive News
ICU SeaStar Medical	3.3212 of 5 stars	$2.95 -1.0%	$8.00 +171.2%	-64.7%	$13.01M	$1.23M	N/A	2
IRIX IRIDEX	1.7929 of 5 stars	$0.68 -2.5%	$3.00 +339.6%	-51.5%	$11.99M	$52.67M	N/A	120	Short Interest Increase

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ZYXI) was last updated on 9/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Zynex (ZYXI) Competitors